C-REACTIVE PROTEIN AS A BIOMARKER FOR IMPROVED EFFICACY OF LENZILUMAB IN PATIENTS WITH COVID-19: RESULTS FROM THE LIVE-AIR TRIAL
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503207/ http://dx.doi.org/10.1016/j.chest.2021.08.029 |
_version_ | 1784581064045363200 |
---|---|
author | TEMESGEN, ZELALEM BURGER, CHARLES BAKER, JASON POLK, CHRISTOPHER LIBERTIN, CLAUDIA KELLEY, COLLEEN MARCONI, VINCENT ORENSTEIN, ROBERT CATTERSON, VICTORIA ARONSTEIN, WILLIAM DURRANT, CAMERON CHAPPELL, DALE CHAPPELL, GABRIELLE AHMED, OMAR BADLEY, ANDREW |
author_facet | TEMESGEN, ZELALEM BURGER, CHARLES BAKER, JASON POLK, CHRISTOPHER LIBERTIN, CLAUDIA KELLEY, COLLEEN MARCONI, VINCENT ORENSTEIN, ROBERT CATTERSON, VICTORIA ARONSTEIN, WILLIAM DURRANT, CAMERON CHAPPELL, DALE CHAPPELL, GABRIELLE AHMED, OMAR BADLEY, ANDREW |
author_sort | TEMESGEN, ZELALEM |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8503207 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American College of Chest Physicians. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85032072021-10-12 C-REACTIVE PROTEIN AS A BIOMARKER FOR IMPROVED EFFICACY OF LENZILUMAB IN PATIENTS WITH COVID-19: RESULTS FROM THE LIVE-AIR TRIAL TEMESGEN, ZELALEM BURGER, CHARLES BAKER, JASON POLK, CHRISTOPHER LIBERTIN, CLAUDIA KELLEY, COLLEEN MARCONI, VINCENT ORENSTEIN, ROBERT CATTERSON, VICTORIA ARONSTEIN, WILLIAM DURRANT, CAMERON CHAPPELL, DALE CHAPPELL, GABRIELLE AHMED, OMAR BADLEY, ANDREW Chest Late Breaking American College of Chest Physicians. Published by Elsevier Inc. 2021-10 2021-10-11 /pmc/articles/PMC8503207/ http://dx.doi.org/10.1016/j.chest.2021.08.029 Text en Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Late Breaking TEMESGEN, ZELALEM BURGER, CHARLES BAKER, JASON POLK, CHRISTOPHER LIBERTIN, CLAUDIA KELLEY, COLLEEN MARCONI, VINCENT ORENSTEIN, ROBERT CATTERSON, VICTORIA ARONSTEIN, WILLIAM DURRANT, CAMERON CHAPPELL, DALE CHAPPELL, GABRIELLE AHMED, OMAR BADLEY, ANDREW C-REACTIVE PROTEIN AS A BIOMARKER FOR IMPROVED EFFICACY OF LENZILUMAB IN PATIENTS WITH COVID-19: RESULTS FROM THE LIVE-AIR TRIAL |
title | C-REACTIVE PROTEIN AS A BIOMARKER FOR IMPROVED EFFICACY OF LENZILUMAB IN PATIENTS WITH COVID-19: RESULTS FROM THE LIVE-AIR TRIAL |
title_full | C-REACTIVE PROTEIN AS A BIOMARKER FOR IMPROVED EFFICACY OF LENZILUMAB IN PATIENTS WITH COVID-19: RESULTS FROM THE LIVE-AIR TRIAL |
title_fullStr | C-REACTIVE PROTEIN AS A BIOMARKER FOR IMPROVED EFFICACY OF LENZILUMAB IN PATIENTS WITH COVID-19: RESULTS FROM THE LIVE-AIR TRIAL |
title_full_unstemmed | C-REACTIVE PROTEIN AS A BIOMARKER FOR IMPROVED EFFICACY OF LENZILUMAB IN PATIENTS WITH COVID-19: RESULTS FROM THE LIVE-AIR TRIAL |
title_short | C-REACTIVE PROTEIN AS A BIOMARKER FOR IMPROVED EFFICACY OF LENZILUMAB IN PATIENTS WITH COVID-19: RESULTS FROM THE LIVE-AIR TRIAL |
title_sort | c-reactive protein as a biomarker for improved efficacy of lenzilumab in patients with covid-19: results from the live-air trial |
topic | Late Breaking |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503207/ http://dx.doi.org/10.1016/j.chest.2021.08.029 |
work_keys_str_mv | AT temesgenzelalem creactiveproteinasabiomarkerforimprovedefficacyoflenzilumabinpatientswithcovid19resultsfromtheliveairtrial AT burgercharles creactiveproteinasabiomarkerforimprovedefficacyoflenzilumabinpatientswithcovid19resultsfromtheliveairtrial AT bakerjason creactiveproteinasabiomarkerforimprovedefficacyoflenzilumabinpatientswithcovid19resultsfromtheliveairtrial AT polkchristopher creactiveproteinasabiomarkerforimprovedefficacyoflenzilumabinpatientswithcovid19resultsfromtheliveairtrial AT libertinclaudia creactiveproteinasabiomarkerforimprovedefficacyoflenzilumabinpatientswithcovid19resultsfromtheliveairtrial AT kelleycolleen creactiveproteinasabiomarkerforimprovedefficacyoflenzilumabinpatientswithcovid19resultsfromtheliveairtrial AT marconivincent creactiveproteinasabiomarkerforimprovedefficacyoflenzilumabinpatientswithcovid19resultsfromtheliveairtrial AT orensteinrobert creactiveproteinasabiomarkerforimprovedefficacyoflenzilumabinpatientswithcovid19resultsfromtheliveairtrial AT cattersonvictoria creactiveproteinasabiomarkerforimprovedefficacyoflenzilumabinpatientswithcovid19resultsfromtheliveairtrial AT aronsteinwilliam creactiveproteinasabiomarkerforimprovedefficacyoflenzilumabinpatientswithcovid19resultsfromtheliveairtrial AT durrantcameron creactiveproteinasabiomarkerforimprovedefficacyoflenzilumabinpatientswithcovid19resultsfromtheliveairtrial AT chappelldale creactiveproteinasabiomarkerforimprovedefficacyoflenzilumabinpatientswithcovid19resultsfromtheliveairtrial AT chappellgabrielle creactiveproteinasabiomarkerforimprovedefficacyoflenzilumabinpatientswithcovid19resultsfromtheliveairtrial AT ahmedomar creactiveproteinasabiomarkerforimprovedefficacyoflenzilumabinpatientswithcovid19resultsfromtheliveairtrial AT badleyandrew creactiveproteinasabiomarkerforimprovedefficacyoflenzilumabinpatientswithcovid19resultsfromtheliveairtrial |